Tisotumab vedotin in combination with carboplatin and pembrolizumab with or without bevacizumab in first-line recurrent or metastatic cervical cancer: First disclosure of arm H from the ENGOT-cx8/GOG-3024/innovaTV 205 study
Toon Van Gorp, Ignace Vergote, Leslie Randall, Jacqueline M. Tromp et autres
be, us, nl, it, cz, ps, es, dk (code pays fourni par la source)